Compound heterozygous factor XI deficiency in a twin pregnancy with uterus didelphys: a case report

Introduction Factor XI (FXI) deficiency is a rare autosomal recessive bleeding disorder that causes coagulopathy. While the implications of general coagulation dysfunction during pregnancy are recognized, reports on severe compound heterozygous FXI deficiency complicated by a uterus didelphys and a twin pregnancy are exceedingly rare. Case Presentation We herein present a 29-year-old woman with a monochorionic diamniotic twin pregnancy and a uterus didelphys who was admitted at 32 weeks and 3 days of gestation due to a prolonged APTT. Despite lacking prior clinical hemorrhagic symptoms, she was diagnosed with severe FXI deficiency driven by a compound heterozygous mutation in the F11 gene. Managed by a multidisciplinary team (MDT), she underwent an emergency cesarean section under general anesthesia at 36 weeks and 1 day, successfully delivering both infants. Her perioperative coagulation profile was optimized via intravenous fresh frozen plasma that targeted the clinical hemostasis rather than the absolute laboratory values. Diligent monitoring confirmed no abnormal postpartum hemorrhage (PPH), and the woman remained hemodynamically stable. Both premature infants subsequently developed necrotizing enterocolitis but fully recovered following comprehensive treatment. Conclusion The primary hazard associated with severe FXI deficiency is PPH, and there is often a lack of significant correlation between the severity of clinical bleeding and laboratory values. Therefore, the prenatal assessment and peripartum management of this rare coagulopathy pose significant challenges. Prompt MDT recognition, individualized intervention, and ongoing care for pregnant individuals affected by inherited bleeding disorders are thus crucial for optimizing maternal and neonatal health outcomes.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-19
DOI
https://doi.org/10.3389/fphar.2026.1987744
Primary Topic
Hemophilia Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Compound heterozygous factor XI deficiency in a twin pregnancy with uterus didelphys: a case report

Hua Liao, Mengmeng Sun, Hongyan Liu, Yanxi Jia et al.
Frontiers in Pharmacology
Hemophilia Treatment and Research
article

Compound heterozygous factor XI deficiency in a twin pregnancy with uterus didelphys: a case report

Hua Liao, Mengmeng Sun, Hongyan Liu, Yanxi Jia, Haiyan Yu
article en

Abstract

Introduction Factor XI (FXI) deficiency is a rare autosomal recessive bleeding disorder that causes coagulopathy. While the implications of general coagulation dysfunction during pregnancy are recognized, reports on severe compound heterozygous FXI deficiency complicated by a uterus didelphys and a twin pregnancy are exceedingly rare. Case Presentation We herein present a 29-year-old woman with a monochorionic diamniotic twin pregnancy and a uterus didelphys who was admitted at 32 weeks and 3 days of gestation due to a prolonged APTT. Despite lacking prior clinical hemorrhagic symptoms, she was diagnosed with severe FXI deficiency driven by a compound heterozygous mutation in the F11 gene. Managed by a multidisciplinary team (MDT), she underwent an emergency cesarean section under general anesthesia at 36 weeks and 1 day, successfully delivering both infants. Her perioperative coagulation profile was optimized via intravenous fresh frozen plasma that targeted the clinical hemostasis rather than the absolute laboratory values. Diligent monitoring confirmed no abnormal postpartum hemorrhage (PPH), and the woman remained hemodynamically stable. Both premature infants subsequently developed necrotizing enterocolitis but fully recovered following comprehensive treatment. Conclusion The primary hazard associated with severe FXI deficiency is PPH, and there is often a lack of significant correlation between the severity of clinical bleeding and laboratory values. Therefore, the prenatal assessment and peripartum management of this rare coagulopathy pose significant challenges. Prompt MDT recognition, individualized intervention, and ongoing care for pregnant individuals affected by inherited bleeding disorders are thus crucial for optimizing maternal and neonatal health outcomes.

Frontiers in PharmacologyVol. 17
Sichuan University (CN), West China Second University Hospital of Sichuan University (CN)
Hemophilia Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon